News & Updates

Among individuals living with depression and anxiety, the use of electronic wearable devices (EWDs) might be an indicator of their intent to lose weight and in turn may be valuable as a starting point for clinical interactions aimed at improving physical health, according to a recent study.

For patients with type 2 diabetes mellitus (T2DM), consumption of fruits and engagement in physical activity help cut the risk of death from all cause, cardiovascular disease (CVD), and stroke, as reported in a study.

Namodenoson, an A3 adenosine receptor (A3AR) agonist, shows clinical activity against nonalcoholic fatty liver disease (NAFLD) with or without nonalcoholic steatohepatitis (NASH), according to data from a phase II study.

Reduced-dose treatment with androgen receptor pathway inhibitors (ARPI) lead to poorer oncological outcomes relative to full-dose regimens in castration-resistant prostate cancer (CRPC), a recent study has found.